WallStreetZenWallStreetZen

NASDAQ: AZN
Astrazeneca PLC Stock Forecast, Predictions & Price Target

Analyst price target for AZN

Based on 3 analysts offering 12 month price targets for Astrazeneca PLC.
Min Forecast
$75.00+18.07%
Avg Forecast
$78.67+23.85%
Max Forecast
$82.00+29.09%

Should I buy or sell AZN stock?

Based on 4 analysts offering ratings for Astrazeneca PLC.
Buy
Strong Buy
1 analysts 25%
Buy
2 analysts 50%
Hold
1 analysts 25%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their AZN stock forecasts and price targets.

AZN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
BMO Capital
Top 12%
89
BuyInitiates Coverage On$82.00+29.09%2023-01-05
SVB Leerink
Bottom 2%
2
BuyMaintains$79.00+24.37%2022-11-14
Argus Research
Top 14%
87
Strong BuyUpgrades$75.00+18.07%2022-08-29
DZ Bank
Top 32%
69
HoldUpgradesN/AN/A2022-02-11

1 of 1

Forecast return on equity

Is AZN forecast to generate an efficient return?
Company
N/A
Industry
15.02%
Market
13.26%

Forecast return on assets

Is AZN forecast to generate an efficient return on assets?
Company
N/A
Industry
6.45%

AZN earnings per share forecast

What is AZN's earnings per share in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$3.69+564.86%
Avg 2 year Forecast
$4.41+694.59%
Avg 3 year Forecast
$5.14+826.13%
AZN's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

AZN revenue forecast

What is AZN's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$46.3B+2.48%
Avg 2 year Forecast
$50.6B+12.11%
Avg 3 year Forecast
$56.9B+25.97%
AZN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

AZN earnings growth forecast

How is AZN forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
109.97%
Industry
27.02%
Market
21.89%
AZN's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
AZN's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
AZN's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

AZN revenue growth forecast

How is AZN forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
7.72%
Industry
2.8%
Market
9.2%
AZN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
AZN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

AZN vs General Drug Manufacturer Stocks

TickerPricePrice TargetUp/downsideConsensus
AZN$63.52$78.67+23.85%Buy
NVS$85.47N/AN/AHold
BMY$74.53$80.40+7.88%Buy
PFE$43.76$53.08+21.29%Buy
ABBV$145.02$165.00+13.78%Buy

Astrazeneca Stock Forecast FAQ

Is Astrazeneca Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: AZN) stock is to Buy AZN stock.

Out of 4 analysts, 1 (25%) are recommending AZN as a Strong Buy, 2 (50%) are recommending AZN as a Buy, 1 (25%) are recommending AZN as a Hold, 0 (0%) are recommending AZN as a Sell, and 0 (0%) are recommending AZN as a Strong Sell.

If you're new to stock investing, here's how to buy Astrazeneca stock.

What is AZN's earnings growth forecast for 2023-2025?

(NASDAQ: AZN) Astrazeneca's forecast annual earnings growth rate of 109.97% is forecast to beat the US Drug Manufacturers - General industry's average forecast earnings growth rate of 27.02%, and and it is also forecast to beat the US market's average forecast earnings growth rate of 21.89%.

Astrazeneca's earnings in 2023 is $2,039,000,000.On average, 5 Wall Street analysts forecast AZN's earnings for 2023 to be $5,712,120,000, with the lowest AZN earnings forecast at $5,448,960,000, and the highest AZN earnings forecast at $6,052,680,000. On average, 3 Wall Street analysts forecast AZN's earnings for 2024 to be $6,826,680,000, with the lowest AZN earnings forecast at $6,594,480,000, and the highest AZN earnings forecast at $6,996,960,000.

In 2025, AZN is forecast to generate $7,956,720,000 in earnings, with the lowest earnings forecast at $7,678,080,000 and the highest earnings forecast at $8,250,840,000.

What is AZN's revenue growth forecast for 2023-2025?

(NASDAQ: AZN) Astrazeneca's forecast annual revenue growth rate of 7.72% is forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 2.8%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.2%.

Astrazeneca's revenue in 2023 is $45,154,000,000.On average, 3 Wall Street analysts forecast AZN's revenue for 2023 to be $71,633,306,808,000, with the lowest AZN revenue forecast at $71,254,440,000,000, and the highest AZN revenue forecast at $72,152,280,000,000. On average, 3 Wall Street analysts forecast AZN's revenue for 2024 to be $78,363,902,448,000, with the lowest AZN revenue forecast at $75,339,658,440,000, and the highest AZN revenue forecast at $82,545,552,000,000.

In 2025, AZN is forecast to generate $88,053,336,000,000 in revenue, with the lowest revenue forecast at $84,076,524,000,000 and the highest revenue forecast at $92,030,148,000,000.

What is AZN's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: AZN) forecast ROA is N/A, which is lower than the forecast US Drug Manufacturers - General industry average of 6.45%.

What is AZN's Price Target?

According to 3 Wall Street analysts that have issued a 1 year AZN price target, the average AZN price target is $78.67, with the highest AZN stock price forecast at $82.00 and the lowest AZN stock price forecast at $75.00.

On average, Wall Street analysts predict that Astrazeneca's share price could reach $78.67 by Jan 5, 2024. The average Astrazeneca stock price prediction forecasts a potential upside of 23.85% from the current AZN share price of $63.52.

What is AZN's Earnings Per Share (EPS) forecast for 2023-2025?

(NASDAQ: AZN) Astrazeneca's current Earnings Per Share (EPS) is $0.56. On average, analysts forecast that AZN's EPS will be $3.69 for 2023, with the lowest EPS forecast at $3.52, and the highest EPS forecast at $3.91. On average, analysts forecast that AZN's EPS will be $4.41 for 2024, with the lowest EPS forecast at $4.26, and the highest EPS forecast at $4.52. In 2025, AZN's EPS is forecast to hit $5.14 (min: $4.96, max: $5.33).

What is AZN's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: AZN) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.